Global /China /Healthcare /Drug Manufacturers - General /000999

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.

000999

• SHE: 000999 • Delayed

25.91CNY -0.6%

3.83 USD

As of 11 June 2026, China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. has a market cap of $6.4B USD, ranking #3129 globally and #550 in China. It ranks #229 in the Healthcare sector, and #86 in the Drug Manufacturers - General industry.

Global Rank

3129

Country Rank

550

Sector Rank

229

Industry Rank

Key Stats

Market Cap

$6.4BUSD

43.37B CNY

Enterprise Value

$8.25BUSD

55.88B CNY

Revenue (TTM)

$4.85BUSD

32.88B CNY

EBITDA (TTM)

$803.76MUSD

5.44B CNY

Net Income (TTM)

$476.31MUSD

3.23B CNY

EBITDA Margin

17%

Profit Margin

9.8%

PE Ratio

13.4

Forward PE

11.4

PS Ratio

1.3

PB Ratio

1.1

EV/EBITDA

10.0

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Wen Duo Wu open_in_new

Employees

30,304

Founded

1999

Website

999.com.cn open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-0.6%	-5%	-7.3%	-7.8%	-10%	-9%	-19%	-26%	75%

News

Markets

Exchange	Ticker	Price	Quotes
Shenzhen Stock Exchange (SHE / SZSE) MIC: XSHE PRIMARY	000999 华润三九医药股份有限公司 Class A ISIN: CNE0000011K8 Shares Out.: Shares Outstanding: 1.664B¹ Shares Float: 609.975M² TV: TradingView: SZSE: 000999 SA: Stock Analysis: SHE: 000999 YF: Yahoo Finance: 000999.SZ GF: Google Finance: SHE: 000999 BA: Barron's: 000999 MS: Morningstar: XSHE: 000999	25.91 CNY	TV: TradingView: SZSE: 000999 SA: Stock Analysis: SHE: 000999 YF: Yahoo Finance: 000999.SZ GF: Google Finance: SHE: 000999 BA: Barron's: 000999 MS: Morningstar: XSHE: 000999

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in the People’s Republic of China and internationally. The company offers health consumer products (CHC), including cold, flu, skin, gastrointestinal, cough, orthopedics, pediatrics drugs, and dietary nutritional supplements; and prescription drug products, such as anti-tumor, cardiovascular and cerebrovascular, digestive system, orthopedics, pediatrics, anti-infection, and other treatment areas; Chinese medicine health products; and vitamins, minerals, protein powder, collagen, probiotics, health foods, and formula granules. It also provides related health services. The company was formerly known as Sanjiu Pharmaceutical Co., Ltd. and changed its name to China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. in February 2010. China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. was incorporated in 1999 and is headquartered in Shenzhen, China. China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. is a subsidiary of China Resources Pharmaceutical Group Limited.

Similar Companies

Industry: Drug Manufacturers - General (China)

Name	Market Cap (USD) diff.	PE	Country
Jiangsu Hengrui Pharmaceuticals Co.,Ltd SSE: 600276	$53.86B 364.89B CNY 741%	44.9	China
WuXi AppTec Co., Ltd. SSE: 603259	$49.65B 336.36B CNY 676%	17.2	China
Hansoh Pharmaceutical Group Company Ltd. SHEK: 3692	$28.52B 223.48B HKD 345%	35.7	China
Innovent Biologics, Inc. SHEK: 1801	$18.8B 147.32B HKD 194%	162.3	China
Sichuan Biokin Pharmaceutical Co.,Ltd. SSE: 688506	$16.52B 111.89B CNY 158%	-	China
Akeso, Inc. SHEK: 9926	$16.01B 125.46B HKD 150%	-	China

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 12K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 8K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 6K%	97.4	United States
Roche Holding AG SIX: RO	$321.16B 256.25B CHF 5K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$288.62B 215.59B GBP 4K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$274.35B 218.9B CHF 4K%	20.5	Switzerland

chevron_leftBack